Medically reviewed by: Jayden Lee, PharmD, EMBA Jayden Lee, PharmD, EMBA, is the PlexusDx Medical Science Liaison with a PharmD and MBA specializing in pharmacogenomics and clinical product development, with a proven ability to bridge the gap between genomic research and practical patient outcomes
For those considering a switch between delivery methods, our guide on tirzepatide tablets versus injections covers the tradeoffs in detail
Reduction of obesity-related health concerns: It can assist in managing issues like high blood pressure and sleep apnea
The criteria below reflect the standards clinics commonly use during an initial evaluation, though a full medical assessment always determines the final answer
Rotating injection sites reduces the risk of injection site reactions
September 5th, 2025: Research Suggests GLP-1 Medications May Raise Kidney Cancer Risk Amid Growing Litigation A new study published in JAMA Oncology suggests that GLP-1 receptor agonists such as Ozempic and Mounjaro could increase the risk of kidney cancer, despite appearing to lower the risk of certain other cancers
